Gilead Sciences names Daniel O’Day chairman and CEODaniel O'Day is leaving Roche to serve as chairman and CEO of Gilead Sciences, effective March 1, 2019. Lupin introduces generic RapafloLupin rolls out generic Rapaflo, which had a market value of about $198.5 million. FDA gives Lupin's generic Eliquis tentative approval The FDA has given tentative clearance for Lupin's generic Eliquis, which had a market value of about $6.4 billion. Innovation's Phil Samples elected to AMSUS board Innovation's Phil Samples has been elected to the board of AMSUS, the Society of Federal Health Professionals. Walgreens unveils Missouri medication disposal kiosks The chain on Tuesday unveiled the first disposal kiosks at one of the 14 locations in the state that house them alongside Missouri Gov. Mike Parson.r Hikma launches generic Onfi Hikma is offering clobazam oral suspension and clobazam tablets, which had a market value of $260 million and $601 million respectively. FDA issues draft guidance to ensure safety of compounded drugs The FDA's revised draft guidance aims to protect patients from contaminated or substandard compounded drugs. Presidential historian Doris Kearns Goodwin to address NACDS Annual Meeting NACDS Annual Meeting attendees will glean insights from renowned presidential historian Doris Kearns Goodwin. HFAP unveils compounding pharmacy certification HFAP's compounding pharmacy certification program ensures high standards of quality. Sun Pharma gets FDA green light for generic Ganirelix The Food and Drug Administration has cleared Sun Pharma's generic Ganirelix, which had a market value of about $67 million, according to IQVIA data. First Previous 517 518 519 520 521 Next Last
